DekaBank Deutsche Girozentrale - ACELRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$88,000
+27.5%
22,5000.0%0.00%0.0%
Q3 2015$69,000
-24.2%
22,500
+4.7%
0.00%0.0%
Q2 2015$91,000
+15.2%
21,500
+4.9%
0.00%0.0%
Q1 2015$79,000
-49.7%
20,500
-12.8%
0.00%
-50.0%
Q4 2014$157,000
+12.1%
23,500
-7.8%
0.00%0.0%
Q3 2014$140,000
-45.3%
25,500
+2.0%
0.00%
-50.0%
Q2 2014$256,000
-16.3%
25,000
-2.0%
0.00%
-20.0%
Q1 2014$306,00025,5000.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders